These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15322325)

  • 1. Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis.
    Futrakul N; Futrakul P; Siriviriyakul P
    Clin Hemorheol Microcirc; 2004; 31(3):197-205. PubMed ID: 15322325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: therapeutic benefit with vasodilators.
    Futrakul P; Pochanugool C; Poshyachinda M; Thamaree S; Yenrudi S; Buranasiri K; Saleekul P; Watana D; Sensirivatana R; Kingwatanakul P
    J Med Assoc Thai; 1992 Jul; 75(7):375-85. PubMed ID: 1293254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic maladjustment and disease progression in nephrosis with FSGS.
    Futrakul N; Siriviriyakul P; Deekajorndej T; Futrakul P
    Ren Fail; 2004 May; 26(3):231-6. PubMed ID: 15354970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
    Futrakul N; Boonyen M; Patumraj S; Siriviriyakul P; Tosukhowong P; Futrakul P
    Clin Hemorheol Microcirc; 2003; 29(3-4):205-10. PubMed ID: 14724343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hemodynamically mediated mechanism of renal disease progression in severe glomerulonephritides or nephrosis.
    Futrakul P; Siriviriyakul P; Patumraj S; Bunnag S; Kulaputana O; Futrakul N
    Clin Hemorheol Microcirc; 2003; 29(3-4):183-7. PubMed ID: 14724339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Vongthavarawat V; Futrakul P; Sirisalipoch S; Chaivatanarat T; Suwanwalaikorn S
    Clin Hemorheol Microcirc; 2006; 34(3):373-81. PubMed ID: 16614461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
    Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
    Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis.
    Futrakul N; Panichakul T; Butthep P; Futrakul P; Jetanalin P; Patumraj S; Siriviriyakul P
    Clin Hemorheol Microcirc; 2004; 31(4):267-72. PubMed ID: 15567896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication.
    Futrakul N; Tosukhowong P; Valyapongpichit Y; Tipprukmas N; Futrakul P; Patumraj S
    Ren Fail; 2002 Jul; 24(4):433-45. PubMed ID: 12212823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study.
    Futrakul P; Poshyachinda M; Mitrakul C
    Clin Nephrol; 1978 Nov; 10(5):180-6. PubMed ID: 729213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Choosing the right treatment approach in focal and segmental glomerular sclerosis with chronic renal failure].
    Valerio F; Sottini L; Turina S; Dallera N; Faberi E; Kenou R; Mazzola G; Scolari F
    G Ital Nefrol; 2008; 25 Suppl 44():S88-S98. PubMed ID: 19048592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular endothelial dysfunction and hemodynamic maladjustment in vesicoureteric reflux.
    Futrakul N; Laohaphaibul A; Futrakul P
    Ren Fail; 2003 May; 25(3):479-83. PubMed ID: 12803512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes.
    Futrakul N; Vongthavarawat V; Sirisalipotch S; Chairatanarat T; Futrakul P; Suwanwalaikorn S
    Clin Hemorheol Microcirc; 2005; 32(1):59-65. PubMed ID: 15665427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Futrakul P; Sitprija V
    Ren Fail; 2007; 29(2):155-8. PubMed ID: 17365929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary focal segmental glomerulosclerosis in adults: response to treatment and outcome].
    Niang A; Hachim K; Zahiri K; Fatihi E; Benghanem M; Ramdani B; Sqalli S; Zaid D
    Dakar Med; 2004; 49(1):13-6. PubMed ID: 15782470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome.
    Futrakul N; Yenrudi S; Sensirivatana R; Watana D; Laohapaibul A; Watanapenphaibul K; Kingwatanakul P; Futrakul P; Futrakul S
    Ren Fail; 2000 May; 22(3):329-35. PubMed ID: 10843243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.